The Smart Glucose Devices Market size was valued at USD 571.45 million in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 6.8% from 2021 to 2029. Smart Glucose Devices permits people with diabetes to determine their blood glucose level continuously else at least once in the day. According to study, it is observed that smart glucose devices are majorly used by patients from the age group of 45-68, as it gives reliable and accurate results of the blood sugar test. The report provides qualitative and quantitative insights on the smart glucose devices industry trends and detail analysis of market size and growth rate of all segments in the market. The global smart glucose devices market is segmented by product, end-user and region.To know about the Research Methodology :- Request Free Sample Report
Smart Glucose Devices Market Dynamics
Increasing number of new product launches in the driver for global smart glucose devices market.
Increasing awareness about glucose monitoring, growth in the number of approvals for smart glucose devices help to increase their usage by developing, developed, and developed economies. Development of advanced wearable products and smart devices along with simple operation technique is driving the global market by 2029. Fast day to day life schedule and increasing reasons causing stress in individuals creates the need for home care smart glucose devices worldwide.Self-monitoring blood glucose (SMBG) devices accounted for the largest share of 65.90% in 2021.
Demand of self-monitoring blood glucose systems from the end user industry is growing as larger number of peoples suffering from diabetes mellitus. Improvement in portable smart glucose devices and ease of use with smart glucose devices is driving the global market during forecast period. Diabetes educators are teaching an ever increasing number of peoples with diabetes to use Smart Monitoring Blood Glucose to increase the life span of patients and try to maintain the sugar level by regular monitoring.The home care segment is expected to have xx% growth rate during the forecast period.
Home-based glucose monitoring smart devices have been largely adopted for self-monitoring of blood glucose and are the most widely used method of short-term glucose monitoring throughout the world. Smart Glucose Devices is an approach where people with or without diabetes can measure their blood sugar levels at their home, hence user convenience is the reason for the growth of the global market. The use of smart glucose devices in checking the effects of their treatment and also in stress management is the reason for use of smart glucose devices and hence the global market is growing.The large research design and methods conducted regarding smart glucose devices in U.S. and Canada is expected largest market share of North America from global market.
High investment by the market players in the non-invasive and smart glucose devices, combined with rising patient’s awareness towards self-monitoring in emerging countries is anticipated to grow the global smart glucose devices market. Development of new software and mobile apps for sugar monitoring is the growth opportunity for the global market in North America. Availability of diabetes care services at public health facilities and identified challenges and solutions needed to increase the scope for the smart glucose devices market to grow globally.
Scope of the Global Smart Glucose Devices Market: Inquire before Buying
Global Smart Glucose Devices Market Report Coverage Details Base Year: 2021 Forecast Period: 2022-2029 Historical Data: 2017 to 2021 Market Size in 2021: US $ 571.45 Mn. Forecast Period 2022 to 2029 CAGR: 6.8% Market Size in 2029: US $ 967.27 Mn. Segments Covered: by Product •Continuous Glucose Monitoring Devices • Self-Monitoring Blood Glucose Systems by End User • Hospitals • Home Care • Diagnostic Centers Smart Glucose Devices Market ,by Region
• North America • Europe • Asia Pacific • Middle East & Africa • South AmericaSmart Glucose Devices Market Key players are:
Medtronic plc, F. Hoffmann-La Roche Ltd. Bayer AG, Lifescan, Inc. Dexcom, Inc., Sanofi, Elly Lilly B Braun Melsungen AG.Frequently Asked questions
1. What is the market size of the Global Smart Glucose Devices Market in 2021? Ans. The market size Global Smart Glucose Devices Market in 2021 was US$ 571.45 Million. 2. What are the different segments of the Global Smart Glucose Devices Market? Ans. The Global Smart Glucose Devices Market is divided into Product and End User. 3. What is the study period of this market? Ans. The Global Smart Glucose Devices Market will be studied from 2021 to 2029. 4. Which region is expected to hold the highest Global Smart Glucose Devices Market share? Ans. The Asia Pacific dominates the market share in the market. 5. What is the Forecast Period of Global Smart Glucose Devices Market? Ans. The Forecast Period of the market is 2022-2029 in the market.
1. Global Smart Glucose Devices Market: Research Methodology 2. Global Smart Glucose Devices Market: Executive Summary 2.1 Market Overview and Definitions 2.1.1. Introduction to Global Smart Glucose Devices Market 2.2. Summary 2.1.1. Key Findings 2.1.2. Recommendations for Investors 2.1.3. Recommendations for Market Leaders 2.1.4. Recommendations for New Market Entry 3. Global Smart Glucose Devices Market: Competitive Analysis 3.1 MMR Competition Matrix 3.1.1. Market Structure by region 3.1.2. Competitive Benchmarking of Key Players 3.2 Consolidation in the Market 3.2.1 M&A by region 3.3 Key Developments by Companies 3.4 Market Drivers 3.5 Market Restraints 3.6 Market Opportunities 3.7 Market Challenges 3.8 Market Dynamics 3.9 PORTERS Five Forces Analysis 3.10 PESTLE 3.11 Regulatory Landscape by region • North America • Europe • Asia Pacific • The Middle East and Africa • Latin America 3.12 COVID-19 Impact 4. Global Smart Glucose Devices Market Segmentation 4.1 Global Smart Glucose Devices Market, by Product (2021-2029) • Continuous Glucose Monitoring Devices • Self-Monitoring Blood Glucose Systems 4.2 Global Smart Glucose Devices Market, by End User (2021-2029) • Hospitals • Home Care • Diagnostic Centers 5. North America Smart Glucose Devices Market(2021-2029) 5.1 North American Smart Glucose Devices Market, by Product (2021-2029) • Continuous Glucose Monitoring Devices • Self-Monitoring Blood Glucose Systems 5.2 North America Smart Glucose Devices Market, by End User (2021-2029) • Hospitals • Home Care • Diagnostic Centers 5.3 North America Smart Glucose Devices Market, by Country (2021-2029) • United States • Canada • Mexico 6. Asia Pacific Smart Glucose Devices Market (2021-2029) 6.1. Asia Pacific Smart Glucose Devices Market, by Product (2021-2029) 6.2. Asia Pacific Smart Glucose Devices Market, by End User (2021-2029) 6.2. Asia Pacific Smart Glucose Devices Market, by Country (2021-2029) • China • India • Japan • South Korea • Australia • ASEAN • Rest Of APAC 7. Middle East and Africa Smart Glucose Devices Market (2021-2029) 7.1. Middle East and Africa Smart Glucose Devices Market, by Product (2021-2029) 7.2. Middle East and Africa Smart Glucose Devices Market, by End User (2021-2029) 7.3. Middle East and Africa Smart Glucose Devices Market, by Country (2021-2029) • South Africa • GCC • Egypt • Nigeria • Rest Of ME&A 8. Latin America Smart Glucose Devices Market (2021-2029) 8.1. Latin America Smart Glucose Devices Market, by Product (2021-2029) 8.2. Latin America Smart Glucose Devices Market, by End User (2021-2029) 8.3 Latin America Smart Glucose Devices Market, by Country (2021-2029) • Brazil • Argentina • Rest Of Latin America 9. European Smart Glucose Devices Market (2021-2029) 9.1. European Smart Glucose Devices Market, by Product (2021-2029) 9.2. European Smart Glucose Devices Market, by End User (2021-2029) 9.3 European Smart Glucose Devices Market, by Country (2021-2029) • UK • France • Germany • Italy • Spain • Sweden • Austria • Rest Of Europe 10. Company Profile: Key players 10.1. Abbott Laboratories 10.1.1. Company Overview 10.1.2. Financial Overview 10.1.3. Global Presence 10.1.4. Capacity Portfolio 10.1.5. Business Strategy 10.1.6. Recent Developments 10.2. Medtronic plc 10.3. F. Hoffmann-La Roche Ltd. 10.4. Bayer AG, Lifescan, Inc. 10.5. Dexcom, Inc. 10.6. Sanofi 10.7. Elly Lilly and Company 10.8. B Braun Melsungen AG.